We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

58 hedge funds and large institutions have $145M invested in Fibrocell Science Inc. in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 15 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,071% more call options, than puts

Call options by funds: $456K | Put options by funds: $21K

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

33% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 15

19% more capital invested

Capital invested by funds: $122M → $145M (+$22.6M)

9% more funds holding

Funds holding: 5358 (+5)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
58
Holders Change
+5
Holders Change %
+9.43%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
20
Reduced
15
Closed
3
Calls
$456K
Puts
$21K
Net Calls
+$435K
Net Calls Change
+$452K
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$197K -$26.7K -372 -11%
OAM
27
Oxford Asset Management
United Kingdom
$174K +$182K +2,532 New
TA
28
Teachers Advisors
New York
$164K
Charles Schwab
29
Charles Schwab
California
$159K
CCM
30
Context Capital Management
California
$157K -$20.5K -286 -14%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$143K +$151K +2,100 New
NC
32
Nexthera Capital
New York
$137K +$144K +2,000 New
CCA
33
Catalyst Capital Advisors
New York
$134K -$287K -4,000 -67%
Wells Fargo
34
Wells Fargo
California
$113K +$113K +1,579 +2,024%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$108K +$12.1K +168 +12%
BIP
36
Brandes Investment Partners
California
$103K
Goldman Sachs
37
Goldman Sachs
New York
$93K -$70.3K -978 -42%
NFA
38
Nationwide Fund Advisors
Ohio
$79K
EEG
39
E.E. Geduld
$69K -$23.9K -333 -25%
AIG
40
American International Group
New York
$65K -$144 -2 -0.2%
PP
41
Paloma Partners
Connecticut
$62K +$65.1K +906 New
Millennium Management
42
Millennium Management
New York
$62K +$65.2K +908 New
SO
43
STRS Ohio
Ohio
$60K
VKH
44
Virtu KCG Holdings
New York
$52K -$52.7K -733 -49%
BA
45
BlackRock Advisors
Delaware
$50K -$27K -376 -34%
Creative Planning
46
Creative Planning
Kansas
$43K +$2.37K +33 +6%
Bank of America
47
Bank of America
North Carolina
$40K +$42K +585 +9,750%
Simplex Trading
48
Simplex Trading
Illinois
$36K +$38.6K +538 New
Deutsche Bank
49
Deutsche Bank
Germany
$28K -$3.66K -51 -11%
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$27K +$2.59K +36 +10%

FCSC Hedge Fund Activity: Q4 2015 in Review

58 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q4 2015, worth a combined $145M — up 19% from $122M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new FCSC positions and 3 closed out — a net gain of 5 holders — while 20 added to existing stakes and 15 trimmed.

The largest buyer was QVT Financial, adding an estimated $206K. The largest seller was Catalyst Capital Advisors, cutting an estimated $287K.

  • 58 institutional investors held Fibrocell Science Inc. (FCSC) as of Q4 2015, up from 53 in Q3 2015.
  • Funds reported $145M of Fibrocell Science Inc. stock for Q4 2015, up 19% quarter-over-quarter.
  • 8 funds opened new Fibrocell Science Inc. positions in Q4 2015 and 3 closed out, a net change of +5 holders.
  • The largest Fibrocell Science Inc. buyer in Q4 2015 was QVT Financial, an estimated $206K added.
  • The largest Fibrocell Science Inc. seller in Q4 2015 was Catalyst Capital Advisors, an estimated $287K sold.

Based on aggregated 13F filings for Q4 2015.